242 related articles for article (PubMed ID: 21440957)
1. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
[No Abstract] [Full Text] [Related]
2. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
[TBL] [Abstract][Full Text] [Related]
3. A clinico-pathologic correlation. Bisphosphonate-related osteonecrosis of the jaws.
Oreadi D; Papageorge MB
J Mass Dent Soc; 2010; 58(4):34-7. PubMed ID: 20225801
[No Abstract] [Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM
J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
[No Abstract] [Full Text] [Related]
5. [Bisphosphonates-induced osteonecrosis of the jaw: CT-findings].
Maksimovic O; Denecke B; Pintoffl JP; Horger M
Rofo; 2008 Apr; 180(4):277-9. PubMed ID: 18432565
[No Abstract] [Full Text] [Related]
6. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.
Mignogna MD; Fedele S; Lo Russo L; Ciccarelli R; Lo Muzio L
J Clin Oncol; 2006 Mar; 24(9):1475-7. PubMed ID: 16549843
[No Abstract] [Full Text] [Related]
7. Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case.
Frei M; Bornstein MM; Schaller B; Reichart PA; Weimann R; Iizuka T
J Oral Maxillofac Surg; 2010 Apr; 68(4):863-7. PubMed ID: 20307770
[No Abstract] [Full Text] [Related]
8. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
[TBL] [Abstract][Full Text] [Related]
9. Sore mandible. Bisphosphonate-associated osteonecrosis.
Damm DD; Fantasia JE
Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
[No Abstract] [Full Text] [Related]
10. Radiology quiz case. Osteonecrosis of the jaw: aminobisphosphonate epidemic.
Junquera L; Gallego L; Villarreal P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1229-31. PubMed ID: 19015457
[No Abstract] [Full Text] [Related]
11. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?
Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Ristow M; Koerdt S; Schuster R; Otto S; Pautke C
J Cancer Res Clin Oncol; 2014 Mar; 140(3):487-93. PubMed ID: 24469255
[TBL] [Abstract][Full Text] [Related]
12. A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancer.
Goldman ML; Denduluri N; Berman AW; Sausville R; Guadagnini JP; Kleiner DE; Brahim JS; Swain SM
Oncology; 2006; 71(3-4):306-8. PubMed ID: 17657174
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-related osteonecrosis of the jaw and left thumb.
Longo R; Castellana MA; Gasparini G
J Clin Oncol; 2009 Dec; 27(35):e242-3. PubMed ID: 19858386
[No Abstract] [Full Text] [Related]
14. Avascular osteonecrosis of the mandible following bisphosphonate therapy.
Chandra PA; Chandra AB; Todd GK
Am J Ther; 2009; 16(1):65-7. PubMed ID: 22573056
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Bozas G; Roy A; Ramasamy V; Maraveyas A
Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: similarities with phossy jaw.
Campisi G; Compilato D; Angelo I; Lo Muzio L; Colella G
Indian J Dent Res; 2012; 23(5):683-5. PubMed ID: 23422621
[TBL] [Abstract][Full Text] [Related]
17. Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma.
Smidt-Hansen T; Folkmar TB; Fode K; Agerbaek M; Donskov F
J Oral Maxillofac Surg; 2013 Sep; 71(9):1532-40. PubMed ID: 23642545
[TBL] [Abstract][Full Text] [Related]
18. Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.
Lobato JV; Maurício AC; Rodrigues JM; Cavaleiro MV; Cortez PP; Xavier L; Botelho C; Hussain NS; Santos JD
J Plast Reconstr Aesthet Surg; 2008; 61(1):99-106. PubMed ID: 18068658
[TBL] [Abstract][Full Text] [Related]
19. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
[TBL] [Abstract][Full Text] [Related]
20. Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.
Herbozo PJ; Briones DL; Ferres AJ; Torrealba RL
J Oral Maxillofac Surg; 2007 Aug; 65(8):1650-4. PubMed ID: 17656297
[No Abstract] [Full Text] [Related]
[Next] [New Search]
